Immuron says Phase 2 Travelan trial results published in Scientific Reports
Immuron reported publication of Phase 2 results for once-daily oral Travelan in Scientific Reports; data were previously presented on March 7, 2024. The trial missed its primary efficacy targets, pressured by an unexpectedly low placebo illness rate that reduced statistical power. Across secondary measures, outcomes co